Normal view MARC view ISBD view

Current controversies in the biological sciences : case studies of policy challenges from new technologies / Karen F. Greif and Jon F. Merz.

By: Greif, Karen F. (Karen Faye), 1952-.
Contributor(s): Merz, Jon F. (Jon Frederick), 1956-.
Series: Basic bioethics. Publisher: Cambridge, MA : MIT, c2007Description: xii, 385 p. ; 24 cm.ISBN: 0262572397; 9780262572392 (pbk.).Subject(s): Medicine -- Research -- Government policy | Medicine -- Research -- Moral and ethical aspectsDDC classification: 610.72 Online resources: Click here to access online
Contents:
Series foreword. - Preface. - Acknowledgments. - 1. An uneasy balance: science advising and the politicization of science. - 2. Big science: The human genome project and the public funding of science. - 3. Who owns the genome? The patenting of human genes. - 4. Manufacturing children: assisted reproductive technologies and self-regulation by scientists and clinicians. - 5. Protecting the public: the FDA and new AIDS drug. - 6. Cosmic science: breast implants and the courts. - 7. Selling science: new cancer treatments and the media. - 8. Concealing evidence: science, big business and the tobacco industry. - 9. Science in the national interest: bioterrorism and civil liberties. - 10. Science misunderstood: genetically modified organisms and international trade. - 11. Dangers in the environment: air pollution policy. - 12. Who lives and who dies: organ transplantation. - 13. Concluding remarks: the challenges of science policy. - Index.
Item type Current location Call number Copy number Status Notes Date due Barcode
Main Collection Taylor's Library-TC
610.72 GRE (Browse shelf) 1 Available GENxx,GENxx,03,GR 5000082084

Includes bibliographical references and index.

Series foreword. - Preface. - Acknowledgments. - 1. An uneasy balance: science advising and the politicization of science. - 2. Big science: The human genome project and the public funding of science. - 3. Who owns the genome? The patenting of human genes. - 4. Manufacturing children: assisted reproductive technologies and self-regulation by scientists and clinicians. - 5. Protecting the public: the FDA and new AIDS drug. - 6. Cosmic science: breast implants and the courts. - 7. Selling science: new cancer treatments and the media. - 8. Concealing evidence: science, big business and the tobacco industry. - 9. Science in the national interest: bioterrorism and civil liberties. - 10. Science misunderstood: genetically modified organisms and international trade. - 11. Dangers in the environment: air pollution policy. - 12. Who lives and who dies: organ transplantation. - 13. Concluding remarks: the challenges of science policy. - Index.

Medicine & health